Real Savings: Medicare-Negotiated Discounts On Cancer Drugs Range From 40%-60%

 
• By Cathy Kelly
  
The CMS price announcement focused on list price discounts, which are not as significant as they look for drugs with big rebates. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Medicare

More from Government Payers